Elevated PCSK9 levels in untreated patients with heterozygous or homozygous familial hypercholesterolemia and the response to high-dose statin therapy.

Journal of the American Heart Association

Volumn 2, Issue 2, 2013, Pages

  Raal, Frederick ^a   Panz, Vanessa ^b   Immelman, Andrew ^b   Pilcher, Gillian ^b  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; PCSK9 PROTEIN, HUMAN; SERINE PROTEINASE; TRIACYLGLYCEROL;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; BLOOD; CASE CONTROL STUDY; DRUG EFFECT; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; GENETICS; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MALE; METABOLISM; STATISTICAL MODEL;

ADULT; CAROTID INTIMA-MEDIA THICKNESS; CASE-CONTROL STUDIES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPOPROTEINEMIA TYPE II; LINEAR MODELS; MALE; PROPROTEIN CONVERTASES; RECEPTORS, LDL; SERINE ENDOPEPTIDASES; TRIGLYCERIDES; YOUNG ADULT;

EID: 84879315149     PISSN: None     EISSN: 20479980     Source Type: None    
DOI: 10.1161/JAHA.112.000028     Document Type: Article

References (0)